Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Invitae offers medical genetics testing for a variety of diseases, disorders, and pediatric conditions.
Invitae shares have lost more than 80% over the past year and a half.
The last two years have been tumultuous, and there are no calm waters in sight.
NVTA earnings call for the period ending September 30, 2023.
NVTA earnings call for the period ending June 30, 2023.
NVTA earnings call for the period ending March 31, 2023.
NVTA earnings call for the period ending December 31, 2022.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.